The 17th Andrew H. Weinberg Memorial Lecture: Enhancing the IQ of Chimeric Antigen Receptor Redirected T cells for Cancer Immunotherapy

Tuesday, May 7 2013
4:00 pm

Location: Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey Center, Room 306 Boston, MA 02215

This annual lecture focuses on the latest achievements in advancing new therapeutic strategies to improve care for cancer patients.

Michael C.V. Jensen, M.D.

Director, Ben Towne Center for Childhood Cancer Research,

Seattle Children’s Hospital, and professor of Hematology-Oncology at the University of Washington School of Medicine.

 

Enhancing the IQ of Chimeric Antigen Receptor Redirected T cells for

Cancer Immunotherapy

Tuesday, May 7, 2013, 4:00 pm

 

Sponsored by the Andrew H. Weinberg Endowment at Dana-Farber,

 Team Andrew, the Jimmy Fund Walk

 and the Medicinal Chemistry Group of the Northeastern Section of the

 American Chemical Society

 

Dana-Farber Cancer Institute,

450 Brookline Avenue,

Yawkey Center, Room 306

Boston, MA 02215

 

The mission of the Andrew H. Weinberg Annual Memorial Fund is to bring together researchers from the field of chemotherapy development and the medical community in an annual symposium to create and foster an environment for cooperative synergy for inspiring and developing new concepts in pediatric cancer research and treatment

 

Contributions accepted at Team Andrew Weinberg at the Jimmy Fund Walk. To contribute, go to:

http://www.jimmyfundwalk.org/faf/donorReg/donorPledge.asp?ievent=1048920&lis=1&kntae1048920=E1E9D17B0CAA40A5811663698C5272ED&supId=367765342

 

Share MassBio

 

BioProcess

Janitronics

EvaluatePharma


 

MassBio